Business

UCB to Acquire San Diego-Based Candid Therapeutics for Up to $2.2 Billion

The deal expands the Belgian pharma giant's presence in T-cell engager antibodies and upends Candid's earlier plans for a reverse merger with Rallybio.

By Look Out SD Staff Yesterday 2 min read

Business

Riverwalk San Diego Construction Advances: 721-Unit Village Nears Concrete Completion

The massive mixed-use development along the San Diego River will include apartments, retail, a grocer, townhomes, and a future trolley station.

By Look Out SD Staff 2 days ago 1 min read

Business

Origami Therapeutics Inks Global Licensing Deal With French Pharma Giant Ipsen

The deal gives Ipsen exclusive worldwide rights to develop Origami's neurodegeneration drug candidate, marking another major deal for SD biotech.

By Look Out SD Staff 3 days ago 1 min read